Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend 
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth 
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth 
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters 
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline 
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy 
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations 
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence 
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth 
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight 
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans 
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers 
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs 
Samsung C&T Corp. posted a 269.9 billion won net profit for the fourth quarter, plunging 23.5 percent from a year earlier, due to reduced gains from equity ties with Samsung Biologics Co and increased costs in its trading business.
Fourth-quarter operating profit stood at 256.4 billion won, down 21 percent from the year before, while revenue rose 6.3 percent to 8.18 trillion won.
Samsung C&T holds a 43.4 percent stake in Samsung Biologics, whose fourth-quarter net profit plummeted 54.3 percent from the previous year to 96.2 billion won.
For the whole of 2020, Samsung C&T's net profit was up 10.8 percent on-year to 1.16 trillion won.
Operating income was 857.1 billion won, down 1.1 percent from a year earlier, while sales fell 1.8 percent to 30.2 trillion won.
Samsung C&T's trading business unit also increased sales by 5.1 percent on-year to 3.6 trillion won, but operating profit dropped 40 percent to 12 billion won due to rising shipping costs.
